Cargando…
Individualized treatment strategies for hyperuricemia informed by a semi‐mechanistic exposure‐response model of uric acid dynamics
To provide insight into pharmacological treatment of hyperuricemia we developed a semi‐mechanistic, dynamical model of uric acid (UA) disposition in human. Our model represents the hyperuricemic state in terms of production of UA (rate, PUA), its renal filtration (glomerular filtration rate, GFR) an...
Autores principales: | Aksenov, Sergey, Peck, Carl C., Eriksson, Ulf G., Stanski, Donald R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828935/ https://www.ncbi.nlm.nih.gov/pubmed/29488355 http://dx.doi.org/10.14814/phy2.13614 |
Ejemplares similares
-
A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases
por: Leander, Jacob, et al.
Publicado: (2021) -
Cadmium exposure and its association with serum uric acid and hyperuricemia
por: Sun, Honglin, et al.
Publicado: (2017) -
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19
por: Kosinsky, Yuri, et al.
Publicado: (2022) -
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates
por: Chu, Wan-Yu, et al.
Publicado: (2022) -
Renal effects of uric acid: hyperuricemia and hypouricemia
por: Park, Jung Hwan, et al.
Publicado: (2020)